1707 Stock Overview
Grape King Bio Ltd produces and sells pharmaceutical preparations, patent medicines, liquid tonics, drinks, and healthy foods in Taiwan, China, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
Rewards
Risk Analysis
No risks detected for 1707 from our risk checks.
Grape King Bio Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$156.00 |
| 52 Week High | NT$189.00 |
| 52 Week Low | NT$147.50 |
| Beta | 0.42 |
| 1 Month Change | -1.58% |
| 3 Month Change | 0.65% |
| 1 Year Change | -12.85% |
| 3 Year Change | -11.86% |
| 5 Year Change | -26.42% |
| Change since IPO | 146.65% |
Recent News & Updates
Recent updates
Grape King Bio (TPE:1707) Knows How To Allocate Capital
Apr 06
Here's Why Grape King Bio (TPE:1707) Can Manage Its Debt Responsibly
Mar 22Grape King Bio's (TPE:1707) Anemic Earnings Might Be Worse Than You Think
Mar 06How Much Did Grape King Bio's(TPE:1707) Shareholders Earn From Share Price Movements Over The Last Year?
Feb 27Grape King Bio (TPE:1707) Seems To Use Debt Quite Sensibly
Nov 20Shareholder Returns
| 1707 | TW Personal Products | TW Market | |
|---|---|---|---|
| 7D | -1.9% | -0.1% | -0.6% |
| 1Y | -12.8% | -13.3% | 29.2% |
Return vs Industry: 1707 matched the TW Personal Products industry which returned -13.3% over the past year.
Return vs Market: 1707 underperformed the TW Market which returned 29.2% over the past year.
Price Volatility
| 1707 volatility | |
|---|---|
| 1707 Average Weekly Movement | 2.2% |
| Personal Products Industry Average Movement | 4.0% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in TW Market | 8.7% |
| 10% least volatile stocks in TW Market | 2.2% |
Stable Share Price: 1707 has not had significant price volatility in the past 3 months.
Volatility Over Time: 1707's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1969 | n/a | n/a | www.grapeking.com.tw |
Grape King Bio Ltd produces and sells pharmaceutical preparations, patent medicines, liquid tonics, drinks, and healthy foods in Taiwan, China, and internationally. It operates through Multi-Level Marketing, Distribution, and Original Design Manufacturer/Original Equipment Manufacturer segments. The company provides kampo maintenance, health regulation, female beauty, school-age health care, and energy drink products, as well as food inspection services.
Grape King Bio Ltd Fundamentals Summary
| 1707 fundamental statistics | |
|---|---|
| Market cap | NT$23.41b |
| Earnings (TTM) | NT$1.45b |
| Revenue (TTM) | NT$10.64b |
15.9x
P/E Ratio2.2x
P/S RatioIs 1707 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1707 income statement (TTM) | |
|---|---|
| Revenue | NT$10.64b |
| Cost of Revenue | NT$2.10b |
| Gross Profit | NT$8.54b |
| Other Expenses | NT$7.08b |
| Earnings | NT$1.45b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 9.81 |
| Gross Margin | 80.26% |
| Net Profit Margin | 13.66% |
| Debt/Equity Ratio | 0% |
How did 1707 perform over the long term?
See historical performance and comparison